Advancements, challenges and future perspectives on peptide-based drugs: Focus on antimicrobial peptides

Eur J Pharm Sci. 2023 Feb 1:181:106363. doi: 10.1016/j.ejps.2022.106363. Epub 2022 Dec 16.

Abstract

Among other health related issues, the rising concerns on drug resistance led to look for alternative pharmaceutical drugs that are effective both against infectious and noninfectious diseases. Antimicrobial peptides (AMPs) emerged as potential therapeutic molecule with wide range of applications. With their limitations, AMPs have gained reputable attentions in research as well as in the pharmaceutical industry. This review highlighted the historical background, research trends, technological advancements, challenges, and future perspectives in the development and applications of peptide drugs. Some vital questions related with the need for pharmaceutical production, factors for the slow and steady journey, the importance of oral bioavailability, and the drug resistance possibilities of AMPs were raised and addressed accordingly. Therefore, the current study is believed to provide a profound understanding in the past and current scenarios and future directions on the therapeutic impacts of peptide drugs.

Keywords: Antibiotics; Antimicrobial peptides; Bioavailability; Drug resistance; Oral delivery; Peptide drugs.

Publication types

  • Review

MeSH terms

  • Anti-Bacterial Agents* / chemistry
  • Anti-Bacterial Agents* / pharmacology
  • Antimicrobial Peptides* / chemistry
  • Antimicrobial Peptides* / pharmacology
  • Communicable Diseases / drug therapy
  • Humans

Substances

  • Anti-Bacterial Agents
  • Antimicrobial Peptides